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biochemical and molecular variations in brain of
mice with parkinsonism
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Background: Parkinson’s disease characterized by oxidative stress and mitochondrial damage in the pars compacta
of substantia nigra remains a challenge to manage with an added disadvantage of side effects of L-levo dopa, the
standard drug used for therapy. Thus, an alternative approach of utilizing natural components would be beneficial
in the management of the disease. The present study was aimed to investigate the potential role of asiaticoside
(As), a trisaccaride triterpene against1 – methyl 4 – phenyl 1,2,3,6 tetrahydropyridine (MPTP)-induced neurotoxicity
in experimental mice.
Methods: Mice were divided into 4 groups: Group I received vehicle saline, group II was treated with 20 mg/kg of
body weight of MPTP (2 doses with 2 h intervals), group III received MPTP along with 50 mg/kg body weight of As
for the 21 consecutive days starting from the day of MPTP intoxication. Group IV received 50 mg/kg body weight
of asiaticoside for the same period serving as drug control. Animals were sacrificed at the end of experimental
period and the striatum and midbrain samples were analyzed for enzyme assays, transmission electron microscopic
(TEM) analysis. Immunofluorescent assay was performed to study the expression of GFAP to detect astrocyte, which
are activated due to neuronal damage. Imunohistochemical studies were carried out to quantify the expression of
Bax and Bcl2, the molecular signatures that would provide clues of the extent of neurodegeneration.
Results: The activities of enzymes were increased on As administration when compared with those of group II
animals. Expressions of Bax and Bcl2 along with GFAP did show significant variations (p < 0.05) on MPTP treatment
when compared to control animals and the changes were found to be reversed significantly (p < 0.05) after
treatment with asiaticoside. TEM analysis also showed attenuated degenerative architecture on As administration.
The mice which received As alone (drug control IV) did not show significant variation from that of the control mice.
Conclusion: The observations suggest that asiaticoside may be efficacious in protecting neurons from the oxidative
damage caused by the insult of MPTP.Introduction
Parkinson’s disease (PD) is one of the major neurode-
generative disorders. The etiology of this disease is likely
due to the combinations of environmental and genetic
factors. Symptomatic hallmarks of PD are tremor, brady-
kinesia, rigidity and postural instability. PD is character-
ized by massive degeneration of dopaminergic neurons
in the substantia nigra pars compacta (SNpc), leading to* Correspondence: vanielango@gmail.com
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distribution, and reproduction in any mediuma severe loss of striatal dopaminergic fibers and to a
massive reduction of dopamine levels in the striatum [1].
The neurons project their axons to the striatum and
utilize dopamine as their neurotransmitter [2] and a pro-
found reduction in striatal dopamine represents the pri-
mary neurochemical alteration in PD. The proapoptotic
protein Bax is highly expressed in the SNpc and if re-
duced would attenuate SNpc developmental neuronal
apoptosis [3]. PD involving such pathology is the second
largest intimidating health hazard next to Alzeimer’s dis-
ease and is currently being managed by drugs such as
Levodopa which only aid in symptomatic relief.ioMed Central Ltd. This is an open access article distributed under the terms of
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oxidants through dietary or pharmacological could reduce
the oxidative stress induced by various degenerating neu-
rotoxins. Literature survey showed evidences of protective
action of Centella asiatica (CA) against MPTP induced
parkinsonism in rats [4]. Traditionally the leaves and stems
of CA are used for various medicinal purposes. CA was
found to protect against monosodium glutamate induced
neurodegeneration owing to its potential antioxidant prop-
erty [5]. It was found to be effective in preventing the cog-
nitive deficits, as well as the oxidative stress caused by
intracerebroventricular administration of streptozotocin,
indicating that CA can act as a free radical scavenger [6].
Further CA was found to increase brain GABA levels in
rat models [7]. Asiaticoside (As) and Asiatic acid (Aa) are
the two major active principles that have been isolated
from CA. Asiaticoside derivatives were found to inhibit or
reduce H2O2 induced cell death and lower intracellular
free radical concentration, protecting aginst the effects of
beta-amyloid neurotoxicity [8].
With such baseline informations on PD pathology and
on asiaticoside, whose mechanisms of neuroprotective
action need to be explored, the current study has been
designed with the hypothesis that Asiaticoside, the active
principle of CA could have an impact on parkinosnic
features in mice.
Thus, the study aims at the exploration of the effect of
asiaticoside against MPTP –induced neurotoxicity in mice,
by evaluating the critical features such as activities of
ATPases, expressions of Bax and Bcl2 and astrocyte activa-




MPTP – HCl and asiaticoside were purchased from
sigma – Aldrich Bangalore. All the Chemicals used for
the study were of analytical grade. Karnovsky’s fixative,
Araldite CY212 (10 ml), DDSA (dodecenylsuccinic an-
hydride) DMP (dimethyl aminomethyl phenol) (0.4 ml),
plasticizer, Uranyl acetate and Lead citrate were used for
electron microscopic analysis.
Animals
Swiss albino mice (BALB/c) (8 – 14 weeks old) weighing
about the 25 – 30 g of weight were used for the study.
Animals were purchased from Tamilnadu Veterinary and
Animal science University (TANUVAS), Madhavaram,
Chennai, India and were housed under standard condi-
tions of temperature (26 ± 1°C) and illumination (12 h
light/dark cycles), water and standard rodent food ad
libitum. The protocol was approved by the Institutional
Animal Ethics Committee of the University of Madras.
(IAEC NO; 01-078-09).Experimental protocol
The mice were injected intraperitoneally (i.p.) with two
administrations of MPTP (20 mg/kg) at 2-h intervals,
the total dose per mice being 40 mg/kg. A total of 24 an-
imals were divided into four groups: group I was treated
with 2 ml of 0.9% NaCl and served as control; group II
received MPTP – HCl (i.p.) at the dosage of 20 mg/kg of
two doses at 2 h interval and served as PD model; group
III treated with MPTP-HCl (i.p) along with 50 mg/kg body
weight of asiaticoside (orally) for 21 consecutive days;
group IV received 50 mg/kg body weight of asiaticoside
(orally) served as drug control. Following the toxicity as-
sessment of both acute and sub chronic [9] studies, the
dosage of 50 mg/kg body weight of asiaticoside was fixed
for the current study. Animals were sacrificed at the end
of the experimental period.Brain tissue collection
The mice were sacrificed by cervical decapitation in the
morning to avoid diurnal variations of the endogenous
amines, enzymes and other antioxidant molecules. Stri-
atal and mid brain portions were separated and weighed.
The brain tissues were excised and examined under
microscope ensuring the sections. The sections were ho-
mogenized (approx. 10% weight/volume) in 0.32 M su-
crose and centrifuged at 1000 \ g for 10 min to remove
cell debris and nuclei. The supernatant was collected and
recentrifuged at 1000 \ g for another 10 min. The resulting
supernatant was layered over 1.2 m sucrose, and centri-
fuged at 34,000 \ g for 50 min at 4°C. The fraction col-
lected between the 0.32 m and 1.2 m sucrose layer was
diluted at 1:1.5 with ice-cold bi-distilled water, further lay-
ered on 0.8 m sucrose, and again centrifuged at 34,000 \ g
for 30 min. The pellet thus obtained was washed, repel-
leted at 20,000 \ g for 20 min, and ruptured with ice-cold
5 mm imidazole-HCl buffer, pH 7.4 and kept in ice for
60 min with occasional vortex at high speed every 5 min
and used for enzyme assay [10].Estimation of ATPases
The activity of Na+/K +ATPases, Ca2+ ATPase and Mg2+
ATPase were evaluated [11-13] in the brain samples.
Normalization in ATPase detection was done by total pro-
tein estimation. The level of total protein was estimated
with bovine serum albumin (BSA) as the standard [14].Statistics
All the grouped data were expressed as mean ± SD. Dif-
ference in means was studied by means of ANOVA
followed by Dunnet’s post hoc test. Results were consid-
ered significant at p < 0.05.
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The tissue sections were deparaffinized in xylene I & xylene
II at 60°C for 20 min each and hydrated through a graded
series of alcohol, the slides were incubated in a citrate buf-
fer (pH 6.0) for three cycles of 5 min each in a microwave
oven for antigen retrieval. The sections were then allowed
to cool to room temperature and then rinsed with TBS, and
treated with 0.3% H2O2 in methanol for 10 min to block
endogenous peroxidase activity. Non-specific binding was
blocked with 3% BSA at room temperature for 1 h. The
sections were then incubated with diluted primary antibody
Bax (1:1000), Bcl-2 (1:1000) from spring Bioscience USA.
The slides were washed with TBS and then incubated with
anti – rabbit/anti mouse HRP – labeled secondary antibody
(Genei, Bangalore, India) at a dilution (1:500) for 1 h in
room temperature. The peroxidase activity was visualized
by treating the slides with 3, 3′ – diaminobenzidine tetrahy-
drochloride (SRL, Mumbai, India); the slides were counter-
stained with Meyer’s hematoxylin. Negative controls were
incubated with TBS instead of primary antibodies. The rela-
tive intensive scoring was done by arbitrary units (i.e. num-
ber of positive cells per 40× field).
Immunofluorescence study for GFAP
Immunofluorescence was performed on the striatal and
mid brain portion of brain tissues. Tissue samples were
fixed in 10% buffered formalin and embedded in paraffin
wax. Sections were cut at 5 μm in thickness and deparaf-
finized in two changes of xylene at 600C for 20 min each
and hydrated through a graded series of alcohol, the slides
were incubated in a citrate buffer (pH 6.0) for three cycles
of 5 min each in a microwave oven for antigen retrieval.
These sections were then allowed to cool to room tem-
perature and then rinsed with TBS and treated with 0.3%
H2O2 in methanol for 10 min to block endogenous perox-
idase activity. Non specific binding was blocked with 3%
BSA at room temperature for 1 h. The sections were then
incubated with following diluted primary antibodies GFAP
(1:100) at 40°C overnight. The slides were washed with
TBS and then incubated with anti-mouse FITC (fluores-
cence isothiocyanate) –labeled secondary antibody (Genei,
Bangalore, India) at a dilution 1:500 for 30 min in room
temperature. Then they were washed thrice with TBS and
mounted in glycerol: PBS mix (1:9). Then slides were
viewed under fluorescence microscope using wavelength
of 590 nm.
Transmission electron microscopy (TEM)
The samples were fixed in Karnovsky’s fixative for 6 – 8 h
at 4°C. These were post fixed in 1% Osmium tetraoxide in
0.1 M phosphate buffer for 2 h at 4°C, dehydrated in ascen-
ding grades of acetone, infiltrated and embedded in araldite
CY212 and polymerized at 60°C for 72 h. Thin (60 –
70 nm) sections were cut with an ultra – microtome. Thesections were mounted on copper grids and stained with
urany1 acetate and lead citrate and observed under a trans-
mission electron microscope.
Results
Table 1 illustrates the activity of membrane bound en-
zymes namely Na+K+, Mg2+, Ca2+ ATPases which were
significantly reduced (p < 0.05) in the striatum and mid-
brain of MPTP induced mice (Group II) when compared
to group I. The activities of ATPases were reported after
normalization of level of total protein. Upon the adminis-
tration of As (Group III), the activities of these enzymes
were increased when compared with those of group II ani-
mals. The mice which received As (drug control IV) did
not show significant variation from that of the control
mice (Table 1).
Bax is a protein of Bcl -2 gene family which promotes
apoptosis. Figures 1 and 2 represent the immunohisto-
chemical staining pattern of Bax in the striatum and mid-
brain respectively of control and experimental groups.
Similarly, Figures 3 and 4 represent the expression of bcl2
in straitum as well as midbrain respectively. The corre-
sponding scoring of the expression pattern were repre-
sented as arbitrary units in Figure 5 (Bax) and 6 (Bcl 2).
MPTP induced mice (Group II) showed a significant re-
duction (p < 0.05) in the number of positively cells of Bcl2
(Figures 3 and 4), when compared with those of control
(Group I), while As treatment significantly (p < 0.05) in-
creased the number of positive cells in Bcl2 when com-
pared with that of group I. In contrast to the above
observation, an increased number of Bax positive cells
was found in MPTP induced mice (Group II) [as com-
pared to group I] and the same was reversed upon the
treatment of As. Figure 5 and 6 shows the Densitometric
pattern of the expression of Bax and Bcl 2 in striatum and
midbrain respectively.
Immunofluorescence of GFAP
Figures 7 and 8 represent the immunofluorescence pat-
tern of GFAP in striatum and mid brian respectively of
the experimental mice. Prominent expression of GFAP
was encountered on MPTP intoxication owing to reactive
astrogliosis following the insult by MPP+. The sections
from As treated mice did show a comparative reduction
in the immunofluorescence of the protein under investiga-
tion suggesting the lesser impact of the insult. Figure 9
shows the Densitometric pattern of the expression of
GFAP in striatum and midbrain.
Transmission electron microscopy
Figures 10 and 11 depict the ultra structural architecture
of striatal tissue and midbrain viewed under transmission
electron microscope. Control mice (Group I) showed nor-
mal nuclei and cytoplasm similar to that of drug control
Table 1 Effect of As on the activities of Na+ K + ATPase, Mg2+ ATPase, Ca2+ ATPase in the striatal and midbrain tissue of control and experimental mice
Striatal tissue Midbrain
Particulars Group I Group II Group III Group IV Group I Group II Group III Group IV
(Control) (MPTP induced) (MPTP induced + AS Treated) (AS Control) (Control) (MPTP induced) (MPTP induced + AS Treated) (AS Control)
Na+ K + ATPase 0.33 ± 0.01 0.25 ± 0.03a* 0.33 ± 0.04b* 0.34 ± 0.06NS 0.34 ± 0.13 0.23 ± 0.03a* 0.34 ± 0.02b* 0.34 ± 0.02NS
Mg2+ ATPase 0.44 ± 0.03 0.32 ± 0.02a* 0.35 ± 0.03b* 0.44 ± 0.04NS 0.44 ± 0.03 0.35 ± 0.06a* 0.43 ± 0.02b* 0.45 ± 0.02NS
Ca2+ ATPase 0.54 ± 0.06 0.34 ± 0.04a* 0.35 ± 0.03b* 0.44 ± 0.08NS 0.54 ± 0.08 0.33 ± 0.01a* 0.46 ± 0.01b* 0.56 ± 0.02NS
Na+ K +, Mg2+, Ca2+ ATPase = μmoles of Pi liberated/min/mg protein. Each value expressed as mean ± S.D for six mice (n = 6) in each group. Statistically significance at *p < 0.05; a group I vs group II, b group II vs

















Figure 2 Immunohistochemical expression pattern of Bax in mid brain. A: Control (group 1); B: MPTP induced (group II); C: MPTP induced + As
treated (group III); D: Drug Control (group IV).
Figure 3 Immunohistochemical expression pattern of Bcl-2 in striatum. A: Control (group 1); B: MPTP induced (group II); C: MPTP induced + As
treated (group III); D: Drug Control (group IV).
Figure 1 Immunohistochemical expression pattern of Bax in striatum. A: Control (group1); B: MPTP induced (group II); C: MPTP induced + As
treated (group III); D: Drug Control (group IV).
Figure 4 Immunohistochemical expression pattern of Bcl-2 in mid brain. A: Control (group 1); B: MPTP induced (group II); C: MPTP induced + As
treated (group III); D: Drug Control (group IV).



























































Figure 5 Each bar represented the mean ± S.D of 6 mice (n = 6). * represents statically significance at P < 0.05. Comparasion were made as
(a) group I vs group II, (b) group II vs group III, (c) group I vs group III, (#) non significant group I vs group IV (scale bar 50 μm) A: Densitometric
pattern of the expression of BAX in the striatum. B: Densitometric pattern of the expression of BAX in the midbrain.
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brain (Group II) showed enlarged axon and neuron fibers
displaying abnormal dense filamentous material, autopha-
gic structure and irregular multi vesicular bodies (arrow)
chromatin condensation was also encountered. MPTP in-
duced As treated mice (Group III) showed lesser intensity
of the above mentioned changes.Discussion
MPTP is oxidized by monoamine oxidase B (MAO-B) to
a 1-methyl-4-phenyl-pyridinium (MPP+). MPP+ is looked
upon as the toxic substrate, which inhibits complex I ac-
tivity in mitochondria [15]. An additional toxic mode of
action involves the dopamine transporter, which carries
MPP+ in dopaminergic neurons [16].Figure 6 Each bar represented the mean ± S.D of 6 mice. * represents
(a) group I vs group II, (b) group II Vs group III, (c) group I vs group III, (#) n
pattern of the expression of Bcl 2 in striatum. B: Densitometric pattern of tNa+K+ –ATPase is the enzyme responsible for the ac-
tive transport of sodium and potassium ions in the ner-
vous system, maintaining and re-establishing, after each
depolarization, the electrochemical gradient necessary
for neuronal excitability and regulation of neuronal cell
volume. This enzyme is present in high concentrations
in brain cellular membranes, consuming about 40 – 50%
of the ATP generated in this tissue [17]. The enzyme is
known to be affected by the redox state of the cell and
reduced antioxidants or antioxidant enzymes activities are
related to reduced Na+ K+ - ATPase activity [18-20]. By
this, ROS are believed to be involved in tissue damage,
resulting in a wide variety of insults [21-23]. Inhibition of
Na+K+ - ATPase activity is found in various neuropatho-
logical conditions, including cerebral ischemia [24] and
neurodegenerative disorders [25-27]. MPTP treated micestatistically significant at P < 0.05. Comparasion were made as
on significant group I vs group IV (scale bar 50 μm) A: Densitometric
he expression of Bcl 2 in midbrain.
Figure 7 Depict the immunofluorescent pattern of GFAP positive cells in striatum and midbrain respectively, exhibiting markedly
increased, ramified form with many fine processes in MPTP treated mice. GFAP immunoreactivity was mild in the striatum and midbrain of
control (Group I) and AS treated mice (Group III). Immunoflurosence expression of GFAP in striatal tissue. A: Control (group 1); B: MPTP induced
(group II); C: MPTP induced + As treated (group III); D: Drug Control (group IV).
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cantly reversed upon by As treatment.
Bcl-2, an anti–apoptotic member of the Bcl–2 family
can bind to Bax to form Bcl–2: Bax heterodimers at-
tenuate the pro–apoptotic effect of Bax [28]. Bcl–2 and
Bax are involved in the regulation of caspase–3 mediated
apoptosis [29]. Bcl–2 can inhibit apoptosis by binding to
the pro – apoptotic Bax, Bcl–xs, and Bad proteins; it is
believed that the Bcl–2/ Bax ratio is a determining factor
for the cell’s fate [30,31]. MPTP is known to decrease the
expression of Bcl–2 and increased expression of Bax in
the striatum [32] thereby tilting the balance towards apop-
tosis. MPTP administration could induce a cell apoptosis
in PD model [33] via its active MPP+ from an impairing
mitochondrial function. The subsequent energy failure with
ATP depletion increases formation of free radicals [34] and
cytochrome C release [35,36]. It is reported that the pri-
mary cultured neurons which over–express Bcl–2 could be
resistant to the toxicity of MPTP [37]. The study exhibited
a comparative increase in the expression of BCl-2 and the
decrease in that of Bax (Group III) suggesting that As could
minimize the effects of MPTP by an yet -to -identify
mechanism.
Astrocytes secrete various neurotoxic substances and
express an enhanced level of glial fibrillary acidic protein
(GFAP), which is considered a marker protein for
astrogliosis [38]. GFAP- positive astrocytes were evident in
the striatum and midbrain portions after the MPTP treat-
ment (Group II, B) as the latter could cause astroglial acti-
vation. These results provide valuable information for theFigure 8 Depict the immunofluorescent pattern of GFAP positive cell
increased, ramified form with many fine processes in MPTP treated m
control (Group I) and AS treated mice (Group III). Immunoflurosence expres
induced (group II); C: MPTP induced + As treated (group III); D: Drug Contropathogenesis of acute stage of Parkinson’s disease [39,40].
Astrocytes react to various neurodegenerative insults rap-
idly, leading to vigorous astrogliosis [41,42]. This intensified
astrocytic activation was not observed in As treatment
(Figures 7 and 8) suggesting the minimal insult by MPTP
in As treated mice and hence minimal reactive astrocytes.
Transmission electron microscopic view of the sections
of striatum and midbrain of As treated mice depicts min-
imal abnormal variations such as irregular multi vesicular
bodies and dense filamentous material when compared to
group II where these changes were more prominent as
seen in Figures 10 and 11. This observation suggests the
neuro-shielding potential of As against MPTP intoxication
in the mice.
The study thus highlights the potential of As to minimize
the Bax which is required for death of neurons that acti-
vates downstream effectors of cell death such as caspases
[43], with a concomitant increase in the anti-apototic Bcl2
[44] by an yet to prove mechanism leading to protection of
cells. By this and also due to the improved activities of
ATPases, As might influence the translocation of transmit-
ters, nutrients, ions, and cellular components between dif-
ferent cellular compartments that could be beneficial for
neuronal integrity as evidenced from the results. Further,
the astroglial activation by MPTP was only less pronounced
by As. Thus, asiaticoside, a triterpenoid of Centella asiatica
is found to have significant neuroprotective mechanism
against MPTP – induced neurotoxicity and thus could be
considered as a potential candidate for further evaluation
against Parkinsonism.s in striatum and midbrain respectively, exhibiting markedly
ice. GFAP immunoreactivity was mild in the striatum and midbrain of




























































Figure 9 Each bar represented the mean ± S.D of 6 mice (n = 6). * represents statistical significant at P < 0.05. Comparasion were made as
(a) group I vs group II, (b) group II Vs group III, (c) group I vs group III, (#) non significant group I vs group IV (scale bar 50 μm) A: Densitometric
pattern of the expression of GFAP in striatum. B: Densitometric pattern of the expression of GFAP in midbrain.
Figure 10 Transmission electron microscopic appearance of striatum. A: Transmission electron microscopic appearance of striatum Control
(group1); B1: low resolution of MPTP induced (group II); B2: high resolution of MPTP induced (group II); C: MPTP induced + As treated (group III);
D: Drug Control (group IV).
Figure 11 Transmission electron microscopic appearance of midbrain. A: Transmission electron microscopic appearance of midbrain Control
(group 1); B1: low resolution of MPTP induced (group II); B2: high resolution of MPTP induced (group II); C: MPTP induced + As treated (group III);
D: Drug Control (group IV).
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